Krystal Biotech, Inc. (KRYS) /

The debt of Krystal Biotech, Inc. over the past 10 years

Chart Krystal Biotech, Inc.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, Krystal Biotech, Inc. had liquid cash of $827.79M and total debt of $0: net cash of $827.79M. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2016 ($1.84M) and lowest at the end of fiscal 2017 ($0).

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$827.79M*$0$827.79M
2024ended Dec 31, 2024$597.52M*$0$597.52M
2023ended Dec 31, 2023$532.18M*$0$532.18M
2022ended Dec 31, 2022$379.17M*$0$379.17M
2021ended Dec 31, 2021$438.1M*$0$438.1M
2020ended Dec 31, 2020$271.26M*$0$271.26M
2019ended Dec 31, 2019$193.69M*$0$193.69M
2018ended Dec 31, 2018$111.76M*$0$111.76M
2017ended Dec 31, 2017$49.59M$0$49.59M
2016ended Dec 31, 2016$1.92M$1.84M$80K

Fiscal years as Krystal Biotech, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Krystal Biotech, Inc.

Companies of a similar size

Not investment advice. This page shows what Krystal Biotech, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.